{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:14:48Z","timestamp":1790234088009,"version":"4.1.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1086\/655761","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T20:32:24Z","timestamp":1279657944000},"page":"611-619","source":"Crossref","is-referenced-by-count":90,"title":["Is It Safe to Discontinue Primary<i>Pneumocystis jiroveci<\/i>Pneumonia Prophylaxis in Patients with Virologically Suppressed HIV Infection and a CD4 Cell Count &lt;200 Cells\/\u03bcL?"],"prefix":"10.1093","volume":"51","member":"286","container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/51\/5\/611\/959533\/51-5-611.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T18:23:34Z","timestamp":1503426214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/655761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1086\/655761"],"URL":"https:\/\/doi.org\/10.1086\/655761","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}